SEC Tracker
Get the app
EYPT · XBRL financial data

EyePoint financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (EYPT's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers1514*1291112*24511*11
Cost of goods and services sold1—111———————
Research and development1718*30303043*59554859*7284
General and administrative1111*14131313*14121411*1514
Total operating expenses3030*45444357*73686371*8898
Operating income (loss)(14)(16)*(33)(35)(33)(45)*(49)(62)(62)(70)*(87)(97)
Interest expense00*00—year only———year only——
Other income (expense)22*4434*4323*23
Income tax expense (benefit)—year only—000*0000*(0)0
Net income (loss)(13)(14)*(29)(31)(29)(41)*(45)(59)(60)(68)*(85)(94)
Earnings per share, basic USD per share(0.33)(0.33)*(0.55)(0.58)(0.54)—(0.65)(0.85)(0.85)—(0.99)(1.09)
Earnings per share, diluted USD per share(0.33)(0.33)*(0.55)(0.58)(0.54)—(0.65)(0.85)(0.85)—(0.99)(1.09)
Weighted average shares, basic millions of shares3842*05354—7000—00
Weighted average shares, diluted millions of shares3842*05354—7000—00

Balance sheet

CSV

Fiscal quarters (EYPT's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents133281271918010085717510278110
Marketable securities3502818917427123318512920414570
Inventory544432232212
Prepaid and other current assets99111012966920256
Total current assets150345318295269383327265216329250189
Property and equipment, net4577888999910
Right-of-use asset555222121222121202020
Total assets160355329324301418363301252364288228
Accounts payable107714712162010101917
Accrued liabilities131816131418181118241622
Total current liabilities646363624949423330373742
Long-term debt0———————————
Lease liability, non-current555222222222221212020
Total liabilities1018979968282645552585862
Accumulated deficit(728)(742)(771)(802)(832)(873)(918)(978)(1,037)(1,105)(1,190)(1,284)
Total stockholders' equity59266250228219337298246200306230166
Total liabilities and equity160355329324301418363301252364288228
Common shares outstanding (cover page) millions of shares355052546869696983838486

Cash flows

CSV

Fiscal quarters (EYPT's year ends in late December)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(13)(14)*(29)(31)(29)(41)*(45)(59)(60)(68)*(85)(94)
Stock-based compensation4*4*139*7*8*87*6*7*1210*
Depreciation and amortization—————year only01*—year only11*
Net cash from operating activities(15)*(23)*(31)(20)*(39)*(36)*(53)(63)*(59)*(65)*(81)(62)*
Purchases of property and equipment2*1*11*2*0*01*1*1*11*
Net cash from investing activities(2)*(47)*21(160)*16*(96)*4048*55*(75)*5975*
Proceeds from issuing common stock—216*———152*——7*167*——
Proceeds from long-term debt0*0*——————————
Repayments of long-term debt0*0*——0*0*——————
Net cash from financing activities10*218*00*12*152*(1)0*7*167*(3)20*
Net change in cash(7)*148*(10)(180)*(11)*20*(15)(14)*3*27*(24)33*

Compare with peers

SIC 3826 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3826 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
EyePoint1100.5(62)*86.2M2.9 quarters 10-QJun 30, 2026
Transcat5.89710*9.4M— 10-QSep 26, 2026
Aehr Test Systems11619*1.8*32.6M— 10-KMay 29, 2026
Allient4215414*17.0M— 10-QJun 30, 2026
Cohu2721735.6*47.3M— 10-QSep 26, 2026
Cytek Biosciences74481.4*130.0M— 10-QJun 30, 2026
Senseonics Holdings4514(30)*52.9M4.7 quarters 10-QJun 30, 2026
Pacific Biosciences of California6139(36)*310.8M6.7 quarters 10-QJun 30, 2026
Mesa Laboratories3160155.6M— 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.